Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Bending the Cost Curve and Here Come the Judge(s)

May 17th 2012

Lately, business and government have done more to "move the needle" in changing healthcare delivery than physicians, scientists, and other clinical professionals.

Dr. Ellis on Heterogeneity Impacting Biomarker Efficacy

May 9th 2012

Dr. Matthew Ellis, from Siteman Cancer Center, on Heterogeneity Impacting Biomarker Efficacy

Dr. Dreicer on Utilizing New Prostate Cancer Therapies

May 9th 2012

Dr. Robert Dreicer, from the Cleveland Clinic, on Utilizing New Prostate Cancer Therapies

'Episode-Based Payment' Could Rein in US Oncology Drug Costs

May 1st 2012

With the recent consideration of the 2010 Affordable Care Act by the US Supreme Court, the rising costs of healthcare have appeared, once again, on our radar screens.

Pazopanib Receives FDA Approval for Treatment of Soft Tissue Sarcoma

April 27th 2012

The FDA has approved pazopanib for the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy.

How Fellows Can Add Value to Their Internal Medicine Residency Program

April 15th 2012

There are many ideas that if followed will not just help you to "do your time" during fellowship, but contribute to the internal medicine residency program.

(Never) A Typical Day in the Life of a Pediatric Hematologist/Oncologist

April 15th 2012

There is no such thing as a typical day. Our days are punctuated by the unexpected and our field is so diverse that we often change what we do over the course of our careers. Time alters us and our field.

The Big Squeeze: How to Handle Higher Costs, Shrinking Reimbursements, and Regulations That Endanger Your Practice

April 13th 2012

Shrinking reimbursements and higher healthcare costs are making it difficult for community oncologists to stay in practice.

Optical Biomarkers Distinguish Risk Levels in Barrett's Esophagus

April 12th 2012

Optical biomarkers derived from nondysplastic metaplastic cells can detect the presence of high-grade dysplasia and adenocarcinoma from Barrett's esophagus.

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

March 19th 2012

Patients with oropharyngeal squamous cell carcinoma who had matted lymph nodes -- nodes that are connected together -- are more likely to metastasize than those without matted lymph nodes.

Tivantinib Extends Time to Progression in HCC Patients

March 19th 2012

Treatment with tivantinib produced a 56% improvement in time-to-progression in patients with hepatocellular carcinoma.

Surgical Breast Biopsy Not Overused, Study Suggests

March 19th 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a recent study published in the Journal of the American College of Radiology.

Where Are the Drugs?

February 24th 2012

In 2011, the FDA reported 232 cancer therapies to be in limited supply. As a result, many patients have had therapies delayed or discontinued, and in some cases, patients have been left without access to appropriate alternatives.

FDA Takes Aggressive Steps to Reduce Drug Shortages

February 21st 2012

The FDA announced plans to strengthen the supply of 2 scarce cancer drugs: methotrexate and Doxil.

John Theurer Cancer Center at Hackensack University Medical Center: Providing Extraordinary Care to the Community

February 14th 2012

Year after year, the John Theurer Cancer Center (JTCC) harnesses the newest technologies and retains world-class oncologists, nurses, and scientists to fulfill its mission of delivering extraordinary care to patients in the community.

Electronic Ordering System Improves Chemotherapy Care

February 7th 2012

Human errors can cause higher-than-expected medication error rates and delays in getting the proper chemotherapy doses to the patients who need them.

January 2012: Trials in Progress

February 1st 2012

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

Molecular Target Testing: Advances Prompt Questions About Costs and Strategies

January 30th 2012

It is increasingly recognized that the realm of molecular diagnostic testing in oncology is undergoing as much change, if not more, as the world of cancer therapeutics.

Radium-223 Properties Conducive to mCRPC Care

December 30th 2011

Radium-223, an alpha-emitting radiopharmaceutical, has been shown to improve overall survival (OS) in men with metastatic castrationresistant prostate cancer (mCRPC) in an interim analysis of the ALSYMPCA trial.

Statins linked to lower risk of prostate cancer mortality in middle-aged men

December 30th 2011

Middle-aged men taking a class of drugs called statins to reduce cholesterol levels were shown to have reduced the risk of mortality due to prostate cancer by approximately 50%, according to a new study...